A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Clinical trial NCT03845387 · COMPLETED

Trial details

NCT number: NCT03845387
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2019-02-26
Primary completion: 2020-02-21
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.